Education
About Us
Working with TipRanks
Follow Us
Omada Health, Inc. (OMDA)
NASDAQ:OMDA
OMDA Stock Chart & Stats
$19.01
-$4.40(-19.47%)
At close: 4:00 PM EDT
$19.01
-$4.40(-19.47%)
Day’s Range― - ―
52-Week Range$14.14 - $28.40
Previous Close$18.29
Volume2.54M
Average Volume (3M)502.58K
Market Cap
$1.13B
Enterprise Value$1.08B
Total Cash (Recent Filing)$198.63M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta3.23
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding57,908,047
10 Day Avg. Volume814,410
30 Day Avg. Volume502,581
Financial Highlights & Ratios
PEG Ratio0.91
Price to Book (P/B)19.84
Price to Sales (P/S)7.55
P/FCF Ratio-33.70
Enterprise Value/Market Cap0.96
Enterprise Value/Revenue5.86
Enterprise Value/Gross Profit9.23
Enterprise Value/Ebitda-92.22
Forecast
1Y Price Target
$28.50Price Target Upside49.92% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)-0.03
Revenue Forecast (FY)$251.72M
Bulls Say, Bears Say
Bulls Say
EarningsOmada's momentum continued with a strong across-the-board 3Q beat compared to CG/consensus estimates, in addition to posting its first quarter with positive adj-EBITDA.
Market PenetrationOmada Health's ~3,000 employer clients representing ~18mn lives as of October 2025 indicates significant market penetration and potential for further growth.
Revenue GrowthA large under-penetrated TAM, recent roll-out of an enhanced GLP-1 companion program, AI investments, and increasing cross-selling momentum provides significant runway for continued 20%+ revenue growth and expanding margins.
Bears Say
Omada Health, Inc. News
OMDA FAQ
What was Omada Health, Inc.’s price range in the past 12 months?
Omada Health, Inc. lowest stock price was $14.14 and its highest was $28.40 in the past 12 months.
What is Omada Health, Inc.’s market cap?
Omada Health, Inc.’s market cap is $1.13B.
When is Omada Health, Inc.’s upcoming earnings report date?
Omada Health, Inc.’s upcoming earnings report date is Aug 06, 2026 which is in 260 days.
How were Omada Health, Inc.’s earnings last quarter?
Omada Health, Inc. released its earnings results on Nov 06, 2025. The company reported -$0.06 earnings per share for the quarter, beating the consensus estimate of -$0.079 by $0.019.
Is Omada Health, Inc. overvalued?
According to Wall Street analysts Omada Health, Inc.’s price is currently Undervalued.
Does Omada Health, Inc. pay dividends?
Omada Health, Inc. does not currently pay dividends.
What is Omada Health, Inc.’s EPS estimate?
Omada Health, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Omada Health, Inc. have?
Omada Health, Inc. has 57,908,047 shares outstanding.
What happened to Omada Health, Inc.’s price movement after its last earnings report?
Omada Health, Inc. reported an EPS of -$0.06 in its last earnings report, beating expectations of -$0.079. Following the earnings report the stock price went down -7.133%.
Which hedge fund is a major shareholder of Omada Health, Inc.?
Currently, no hedge funds are holding shares in OMDA
Omada Health, Inc. Stock Smart Score
Company Description
Omada Health, Inc.
Omada Health is a U.S.-based virtual-care provider offering clinically validated programs for chronic conditions like cardiometabolic disease, musculoskeletal care, and behavioral health—delivered digitally between doctor visits.
OMDA Company Deck
OMDA Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects strong growth in membership and revenue, driven by innovation and operational efficiency. Despite some concerns about cash flow due to debt repayment and reliance on the GLP-1 market segment, the overall financial and strategic outlook remains positive.View all OMDA earnings summariesOMDA Stock 12 Month Forecast
Average Price Target
$28.50
▲(49.92% Upside)
Technical Analysis
Acurx Pharmaceuticals
―
Healthcare Triangle
―
Bluejay Diagnostics
―
Tivic Health Systems
―
Heart Test Laboratories, Inc.
―
Ownership Overview
11.91% Insiders
3.67% Mutual Funds
9.92% Other Institutional Investors
72.99% Public Companies and
Individual Investors